RNA Q2 2024 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-11.7% YoY

Gross Profit

$1M66.4% margin

Operating Income

-$83M-4040.4% margin

Net Income

-$71M-3461.8% margin

EPS (Diluted)

$-0.66

QoQ Revenue Growth

-42.3%

Cash Flow

Operating Cash Flow

-$65M

Free Cash Flow

-$66M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$126M

Stockholders' Equity

$1.2B

Cash & Equivalents

$576M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	-11.7%
Gross Profit	$1M	-$40M	+103.4%
Operating Income	-$83M	-$53M	-57.0%
Net Income	-$71M	-$47M	-50.5%